These articles can be viewed on Newsletter and Journal

Autumn/Winter 2014 – Issue 48

  • Creating a Research Strategy, page 5
  • Update – V-UK Funded Research Projects, page 6
  • The 100,000 Genome Project, page 7
  • Low Mood and Depression, page 9
  • UKIVAS Registry: nearly 2 years in operation, page 10
  • What is “Medical Research”, page 11
  • Potential Side Effects of Corticosteroid treatments, page 12
  • Young Vasculitis UK, page 13
  • Meeting the Professionals, page 21
  • Postgraduate Education Afternoon, Imperial Vasculitis Centre, page 23

Spring 2014 – Issue 47

  • Rituximab approved by NICE, page3
  • Physical activity in patients with GCA – Dr Joanna Robson et al, Oxford, page 6
  • Potted history of the vasculitides. page 10
  • Masterclass – Large vessel vasculitis, page 11
  • Helping ourselves through diet – Jacky Davis. page 18

Autumn 2013 – Issue 46

  • Vasculitis in children: Dr Paul Brogan, page 4
  • The UK Henoch Schonlein Purpura Nephritis Study: Dr Louise Watson, page 6
  • Shingles vaccine for the over 70’s, page 7
  • Clinical Commissioning Groups: Dr Peter Lanyon, page 8
  • Can Tai Chi be helpful?:Alice Muir, page 9
  • Vasculitis: The patient experience: Dr Nina Brown, page 11
  • Dedicated doctors share knowledge, page 15
  • Role of Metacognitions in adapting to living with vasculitis: Helen Mayor, page 17
  • MYPAN research, page 24

Spring 2013 – Issue 45

  • All ANCA aren’t equal in vasculitis: Dr Julie Williams, page 4
  • Infections in people with vasculitis: Dr Mathew Morgan, page 5
  • Vasculitis and the ear: Dr Marcos Martinez Del Pero, page 6
  • Prednisolone and insomnia, page 8
  • Vasculitis Masterclass, page 9
  • Urticarial vasculitis, page 10
  • Renal PatientView, page 13
  • A day at Imperial College, London, page 15

Autumn 2012 – Issue 44

  • Vasculitis and the Eye: Dr Catherine Guly, page 5
  • The inflammatory actions of ANCA-activated neutrophils: review by Maya Anaokar, page 6
  • Patient reported outcome (PRO) questionnaire development for patients with ANCA-associated vasculitis: Dr Jo Robson, page 7
  • Shingles, page 10
  • Cogan’s Syndrome, page 12

Spring 2012 – Issue 43

  • Diagnostic techniques in vasculitis (Report on Dr David Carruthers’ presentation), page 5
  • Why do patients with ANCA Associated vasculitis experience fatigue (Report on Dr Andrew McClean’s presentation), page 6
  • Fatigue a principal contributor to impaired quality of life in ANCA-associated vasculitis (AAV): Review by Maya Anaokar, page 7
  • Clinical review on the diagnosis and management of ANCA-associated vasculitis (AAV): Review by Maya Anaokar, page 7
  • Fertility and Vasculitis: Dr David Jayne, page 9
  • Lupus, diet and lifestyle: by Ani Richardson, page 11

Autumn 2011 – Issue 42

  • The immune system/autoimmunity: Dr Julie Williams, page 4
  • Mycophenolate Mofetil -v- Azathioprine: Review by Maya Anaokar, page 5
  • Walking the tightrope: Dr Richard Watts, page 6
  • Report from AGM (Who gets vasculitis and why?): report prepared by Maya Anaokar, page 8
  • About Stuart Strange, the Trust and Martin Lockwood, page 10
  • Influenza vaccination, page 11
  • Chickenpox and immunosuppressed people: Viv Dunstan, page 12
  • Healthy eating (part 2) – High and low potassium foods: Catherine Cotter, page 15
  • The enlightened patient, page 20

Spring 2011-Issue 41

  • Healthy Eating (part 1) High and low potassium diets: Catherine Cotter, page 5
  • Vasculitis and oral health: John Mills, page 6
  • Blood test monitoring: page 7
  • ANCA-Associated vasculitis – Are Genes Important?: Professor Lorraine Harper, page 8
  • The Welcome Trust Clinical Research Facility, Birmingham: Dr Julie Williams, page 9
  • An updated on Rituximab: Dr David Jayne, page 10
  • Denosumab for prevention of fractures, page 10

Autumn 2010 – Issue 40

  • The Immune system and basis of ANCA associated vasculitis: Dr Neil Holden, page 8
  • Can B cells and neutrophils “talk” to each other?: Dr Neil Holden, page 9
  • All ANCA are equal but some ANCA are more equal than others: Dr Neil Holden, page 9
  • Monoclonal antibody no better than standard treatment but Rituximab may be better for relapsing vasculitis: Review by Maya Anaokar, page 10